Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -0.17%451.26M | -54.47%621.84M | -37.71%452.01M | 18.69%1.37B | --725.6M | 50.86%340.54M | 24.85%1.15B | --225.73M | 187.92%921.67M | --320.11M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -530.60%-43.85M | ---- | -334.08%-6.95M | ---- | 52.67%-266K | -18.40%-1.6M | ---562K | -483.19%-1.35M | ---232K |
| Attributable subsidiary (profit) loss | ---- | --17.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | 136.14%110.32M | ---- | 348.64%46.72M | ---- | -131.48%-6.08M | -64.56%-18.79M | ---2.63M | -8,295.59%-11.42M | ---136K |
| -Other fair value changes | ---- | 136.14%110.32M | ---- | 348.64%46.72M | ---- | -131.48%-6.08M | -64.56%-18.79M | ---2.63M | -8,295.59%-11.42M | ---136K |
| Asset sale loss (gain): | ---- | 161.49%387K | ---- | -60.00%148K | ---- | ---- | -29.79%370K | ---- | --527K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 161.49%387K | ---- | -60.00%148K | ---- | ---- | -29.79%370K | ---- | --527K | ---- |
| Depreciation and amortization: | ---- | 33.53%89.47M | ---- | 39.94%67.01M | ---- | 35.07%15M | 85.25%47.88M | --11.11M | 171.40%25.85M | --9.52M |
| -Amortization of intangible assets | ---- | 449.51%19.78M | ---- | 105.07%3.6M | ---- | 4,620.00%708K | 891.53%1.76M | --15K | --177K | ---- |
| Financial expense | ---- | 16.60%4.31M | ---- | -19.19%3.69M | ---- | -14.51%978K | 71.00%4.57M | --1.14M | 158.41%2.67M | --1.03M |
| Exchange Loss (gain) | ---- | -12,233.33%-9.1M | ---- | 127.27%75K | ---- | --75K | -80.81%33K | ---- | 22.86%172K | --140K |
| Special items | ---- | --12.83M | ---- | ---- | ---- | ---- | -100.76%-870K | ---- | 208,365.45%114.66M | --55K |
| Operating profit before the change of operating capital | -0.17%451.26M | -45.56%803.78M | -37.71%452.01M | 24.88%1.48B | --725.6M | 49.17%350.25M | 12.31%1.18B | --234.79M | 218.54%1.05B | --330.5M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 34.96%-5.65M | ---- | 89.05%-8.69M | ---- | 155.10%36.52M | -224.30%-79.4M | ---66.28M | 64.49%-24.48M | ---68.94M |
| Accounts receivable (increase)decrease | 107.86%15.78M | -3,108.55%-156.23M | -2,765.63%-200.78M | -42.22%5.19M | --7.53M | 105.82%3.31M | 112.05%8.99M | ---56.81M | -277.67%-74.56M | ---19.74M |
| Accounts payable increase (decrease) | ---- | -126.25%-33.12M | ---- | -45.84%126.16M | ---- | -255.11%-40.1M | -48.86%232.95M | --25.85M | 283.82%455.48M | --118.67M |
| Special items for working capital changes | ---- | -1,140.48%-104.9M | ---- | -9.07%10.08M | ---- | -167.34%-5.54M | -86.89%11.09M | --8.23M | -51.58%84.56M | --174.63M |
| Cash from business operations | 85.90%467.05M | -68.69%503.87M | -65.73%251.23M | 18.68%1.61B | --733.14M | 136.26%344.43M | -9.23%1.36B | --145.78M | 179.15%1.49B | --535.12M |
| Other taxs | ---- | 27.77%-159.85M | ---- | -30.16%-221.31M | ---- | -11.03%-39.56M | 23.99%-170.02M | ---35.63M | -395.82%-223.69M | ---45.11M |
| Special items of business | 5.42%-186.75M | ---- | -2,638.65%-197.46M | ---- | ---7.21M | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 421.22%280.3M | -75.21%344.02M | -92.59%53.78M | 17.04%1.39B | --725.93M | 176.77%304.88M | -6.63%1.19B | --110.16M | 159.20%1.27B | --490.01M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 2.37%21.17M | 120.34%73.48M | 105.25%20.68M | 75.05%33.35M | --10.07M | -46.76%5.14M | 202.32%19.05M | --9.66M | 1,612.50%6.3M | --368K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | 550.47%198.18M | ---- | 375.16%30.47M | --6.41M |
| Decrease in deposits (increase) | ---- | 200.00%230M | --110M | ---230M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | 234.10%725K | 2,082.43%1.62M | --217K | -90.48%74K | ---- | ---- | -90.89%777K | ---- | --8.53M | ---- |
| Purchase of fixed assets | 69.71%-19.07M | 23.95%-64.66M | -157.49%-62.97M | -32.33%-85.03M | ---24.45M | -229.88%-29.78M | 0.91%-64.26M | ---9.03M | -369.80%-64.85M | ---13.8M |
| Purchase of intangible assets | 40.04%-12.68M | -258.19%-66.27M | -281.37%-21.14M | 55.36%-18.5M | ---5.54M | 24.65%-1.42M | -485.26%-41.44M | ---1.88M | ---7.08M | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | --500K | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 68.64%4.87B | -13.34%5.38B | 28.94%2.89B | 36.63%6.2B | --2.24B | 185.05%1.43B | 260.45%4.54B | --502.47M | 1,965.80%1.26B | --60.99M |
| Cash on investment | -73.24%-4.87B | 22.90%-5.27B | -9.25%-2.81B | -34.69%-6.83B | ---2.57B | -442.37%-1.49B | -163.22%-5.07B | ---275.37M | -552.21%-1.93B | ---295.46M |
| Other items in the investment business | -1.41%1.47M | -25.70%3.06M | -24.16%1.49M | 29.30%4.12M | --1.96M | 192.89%577K | 22.84%3.18M | --197K | 3,768.66%2.59M | --67K |
| Net cash from investment operations | -107.01%-8.74M | 131.10%286.87M | 135.48%124.71M | -122.02%-922.54M | ---351.49M | -138.34%-86.67M | 39.88%-415.52M | --226.06M | -186.27%-691.14M | ---241.43M |
| Net cash before financing | 52.15%271.56M | 35.55%630.9M | -52.33%178.48M | -39.59%465.42M | --374.44M | -35.10%218.21M | 33.07%770.42M | --336.21M | 132.91%578.95M | --248.58M |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | -33,425.00%-21.46M | ---5.03M | 96.54%-64K | ---1.85M |
| Issuing shares | ---- | 128.91%2.35B | 135.68%2.35B | --1.02B | --995M | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 22.67%-2.06M | -16.60%-4.31M | -33.80%-2.66M | 19.19%-3.69M | ---1.99M | 14.51%-978K | -71.00%-4.57M | ---1.14M | -158.41%-2.67M | ---1.03M |
| Dividends paid - financing | -4,182.45%-565.28M | 98.61%-13.2M | 97.36%-13.2M | -57.42%-949.5M | ---500M | ---400M | -47.71%-603.17M | ---- | -169.12%-408.36M | ---151.74M |
| Absorb investment income | -67.30%2.16M | --6.6M | --6.6M | ---- | ---- | ---- | ---- | ---- | 900.37%108.07M | --10.8M |
| Issuance expenses and redemption of securities expenses | ---- | -4,286.56%-65.27M | -57,415.04%-64.99M | -345.51%-1.49M | ---113K | ---- | 69.44%-334K | ---- | ---1.09M | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -824,196.77%-255.53M | ---31K |
| Net cash from financing operations | -126.22%-587.56M | 8,919.17%2.21B | 379.60%2.24B | 103.65%24.54M | --467.17M | -2,917.51%-411.89M | -16.14%-672.52M | ---13.65M | -287.49%-579.05M | ---149.44M |
| Net Cash | -113.06%-316M | 480.44%2.84B | 187.43%2.42B | 400.50%489.96M | --841.6M | -160.04%-193.68M | 97,993.00%97.89M | --322.56M | -100.10%-100K | --99.14M |
| Begining period cash | 397.20%3.56B | 216.77%715.99M | 216.77%715.99M | 76.40%226.03M | --226.03M | 76.40%226.03M | -0.08%128.14M | --128.14M | 340.71%128.24M | --29.1M |
| Cash at the end | 3.48%3.24B | 397.20%3.56B | 193.64%3.13B | 216.77%715.99M | --1.07B | -92.82%32.35M | 76.40%226.03M | --450.7M | -0.08%128.14M | --128.24M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.